Semaglutide Consultation
Semaglutide mimics the performance of the human-created GLP-1 hormone, and it helps the pancreas release the right amount of insulin when blood sugar levels are high. This process delays gastric emptying, which causes appetite suppression, which leads to smaller portion sizes and fewer cravings. Because of the significant weight loss component and safety, Semaglutide was FDA-approved in 2021 for treating patients who are considered overweight. It offers a new, sustainable way to manage weight by reducing the feeling of hunger and cravings. Semaglutide has been shown to help people lose a significant amount of weight and keep it off much longer than any other weight loss solution on the market.